Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-11

Clinical Trial Update: Study of ZB001 in Chinese Patients With Thyroid Eye Disease [Phase 1]

View source ↗

Summary

Phase 1 study of ZB001 in Chinese patients with Thyroid Eye Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZB001

Snippet

Sponsor: Zenas BioPharma (USA), LLC | Conditions: Thyroid Eye Disease | Phase 1 | Status: COMPLETED